The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial

NCT05642910 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

540

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV-2 Infection

Interventions

DRUG: Azvudine
DRUG: Paxlovid group

Sponsor

Southeast University, China

Collaborators

[object Object]